| Identification | Back Directory | [Name]
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-(pyridine-4-yl)purine | [CAS]
1612191-93-1 | [Synonyms]
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-(pyridine-4-yl)purine
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-(pyridine-4-yl)purine
9-(3-Deoxy-3-fluoro-beta-D-ribofuranosyl)-6-(pyridine-4-yl)purine
9H-?Purine, 9-?(3-?deoxy-?3-?fluoro-?β-?D-?ribofuranosyl)?-?6-?(4-?pyridinyl)?- | [Molecular Formula]
C15H14FN5O3 | [MDL Number]
MFCD29915403 | [MOL File]
1612191-93-1.mol | [Molecular Weight]
331.31 |
| Hazard Information | Back Directory | [Uses]
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-(pyridine-4-yl)purine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
|